drugset / Trial / NCT03592342
Intra-oral Treatment of OLP With Rivelin®-CLO Patches
Phase 2
Completed
140 enrolled
Dermtreat
Proinnovera GmbH · collabX-act Cologne Clinical Research GmbH · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Participants with symptomatic Oral Lichen Planus lesions will be treated with Rivelin® patches containing either 0, 1, 5, or 20 μg clobetasol per patch. Each participant will apply up to 6 patches twice daily for 4 weeks.
Timeline
- Start
- 2018-06-28
- Primary completion
- 2019-12-20
- Completion
- 2019-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | clobetasol propionate | Small molecule | 1 ug | Topical |
| Subject | clobetasol propionate | Small molecule | 5 ug | Topical |
| Subject | clobetasol propionate | Small molecule | 20 ug | Topical |